News Focus
News Focus
Followers 18
Posts 272
Boards Moderated 0
Alias Born 12/05/2005

Re: DocLee post# 744430

Sunday, 01/19/2025 3:57:44 PM

Sunday, January 19, 2025 3:57:44 PM

Post# of 822568

I cannot believe that for all this time Management has been sitting on its collective backside since then having no further contact with NICE



As mentioned, this has been addressed. Here's the transcript of that discussion at the ASM:

LP:

After the MAA, and the commercialization preparation, and those activities, we also need to go through the process of applying for approval for reimbursement. So in the UK, that's a process that is handled by NICE. And NICE has been absolutely wonderful to us. I cannot say enough things wonderful about NICE. They've been supportive. They've been flexible. They're standing by.

We talk to them. They reach out to us every couple of months to check on the status of things. I mean, I couldn't imagine a government agency, that's been so supportive as they've been. What we will need to do is, we'll need to engage specialized consultants to develop, what's referred to, as a health economics model. We have to make an economic model about the cost benefits of the DC vaccine treatment, and how it fits with their policies, and that sort of thing. So, that for sure will be, in our grouping of top priority activities, over the, as we look forward, over the coming 18 month period, 12 months, whatever.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News